<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://www.talby.com/p/three-non-negotiables-that-separate</loc><news:news><news:publication><news:name>AI in Healthcare</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-13T14:58:42+00:00</news:publication_date><news:title>Three non-negotiables that separate regulatory-grade healthcare AI from LLM Pilots</news:title></news:news></url><url><loc>https://www.talby.com/p/why-the-fda-chose-nlp-to-close-a</loc><news:news><news:publication><news:name>AI in Healthcare</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-12T16:21:36+00:00</news:publication_date><news:title>Why the FDA chose NLP to close a blind spot in post-market drug safety</news:title></news:news></url></urlset>